Phosphatidylinositol 3-kinase inhibitors and methods of their use
US7989622B2 · kind B2 · utility
43Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2006 |
| Grant date | Aug 2, 2011 |
| Priority date | — |
| Expiry date | Oct 12, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises small molecule inhibitors of phosphatidylinositol 3-kinase (PI3K), which is associated with a number of malignancies such as ovarian cancer, cervical cancer, breast cancer, colon cancer, rectal cancer, and glioblastomas, among others. Accordingly, the compounds of the present invention are useful for treating, preventing, and/or inhibiting these diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.